Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials

This MSN is the first of two covering supply issues with insulin vials. The second MSN for Humulin® S vials will be issued shortly but should be noted that as the products have similar sounding names appropriate risk minimisation strategies should be implemented to ensure actions are carried out for specific products.

MSN/2024/053

Tier 2 – medium impact

Date of issue: 9th May 2024

  • Humalog® (insulin lispro) 100units/ml 10ml vials are out of stock with an estimated resupply date of late May 2024.
  • NovoRapid® and Trurapi® (insulin aspart) 100units/ml 10ml vials remain available.
  • Admelog® and Lyumjev® (insulin lispro) 100units/ml 10ml vials remain available, however cannot support an increase in demand.
  • Fiasp® (insulin aspart) 100units/ml 10ml vials remain available, however cannot support an increase in demand.
  • Humalog® 100units/ml 3ml cartridges and Humalog KwikPen® and Junior KwikPen® 100 units/ml 3ml pre-filled pens remain available and can support increased demand.

A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

Capture healthcare advisory work not being covered by Pharmacy First to inform our negotiations with Government and NHS.

Click Here